vs
ETSY INC（ETSY）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
ETSY INC的季度营收约是Royalty Pharma plc的1.3倍（$831.5M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 12.6%，领先21.9%），ETSY INC同比增速更快（7.6% vs 4.8%），过去两年ETSY INC的营收复合增速更高（13.3% vs 4.6%）
Etsy是美国电商企业，主打手工制品、复古商品及手工耗材交易，平台品类覆盖珠宝首饰、服饰、家居装饰、家具、玩具、艺术品等。平台规定复古商品需至少有20年历史，卖家可开设独立店铺，每件上架商品收取0.2美元挂牌费，2013年起平台也允许量产商品入驻销售。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
ETSY vs RPRX — 直观对比
营收规模更大
ETSY
是对方的1.3倍
$622.0M
营收增速更快
ETSY
高出2.8%
4.8%
净利率更高
RPRX
高出21.9%
12.6%
两年增速更快
ETSY
近两年复合增速
4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $831.5M | $622.0M |
| 净利润 | $104.7M | $214.2M |
| 毛利率 | 54.8% | — |
| 营业利润率 | 59.6% | 62.4% |
| 净利率 | 12.6% | 34.4% |
| 营收同比 | 7.6% | 4.8% |
| 净利润同比 | 398.3% | 2.9% |
| 每股收益（稀释后） | $0.89 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ETSYRPRX
| Q1 26 | $831.5M | — | ||
| Q4 25 | $881.6M | $622.0M | ||
| Q3 25 | $678.0M | $609.3M | ||
| Q2 25 | $672.7M | $578.7M | ||
| Q1 25 | $651.2M | $568.2M | ||
| Q4 24 | $852.2M | $593.6M | ||
| Q3 24 | $662.4M | $564.7M | ||
| Q2 24 | $647.8M | $537.3M |
净利润ETSYRPRX
| Q1 26 | $104.7M | — | ||
| Q4 25 | $110.7M | $214.2M | ||
| Q3 25 | $75.5M | $288.2M | ||
| Q2 25 | $28.8M | $30.2M | ||
| Q1 25 | $-52.1M | $238.3M | ||
| Q4 24 | $129.9M | $208.2M | ||
| Q3 24 | $57.4M | $544.0M | ||
| Q2 24 | $53.0M | $102.0M |
毛利率ETSYRPRX
| Q1 26 | 54.8% | — | ||
| Q4 25 | 73.1% | — | ||
| Q3 25 | 71.3% | — | ||
| Q2 25 | 71.2% | — | ||
| Q1 25 | 70.5% | — | ||
| Q4 24 | 74.5% | — | ||
| Q3 24 | 72.0% | — | ||
| Q2 24 | 71.6% | — |
营业利润率ETSYRPRX
| Q1 26 | 59.6% | — | ||
| Q4 25 | 14.7% | 62.4% | ||
| Q3 25 | 12.2% | 70.1% | ||
| Q2 25 | 11.4% | 36.3% | ||
| Q1 25 | -3.4% | 94.0% | ||
| Q4 24 | 18.2% | 60.9% | ||
| Q3 24 | 13.1% | — | ||
| Q2 24 | 10.8% | 50.2% |
净利率ETSYRPRX
| Q1 26 | 12.6% | — | ||
| Q4 25 | 12.6% | 34.4% | ||
| Q3 25 | 11.1% | 47.3% | ||
| Q2 25 | 4.3% | 5.2% | ||
| Q1 25 | -8.0% | 41.9% | ||
| Q4 24 | 15.2% | 35.1% | ||
| Q3 24 | 8.7% | 96.3% | ||
| Q2 24 | 8.2% | 19.0% |
每股收益（稀释后）ETSYRPRX
| Q1 26 | $0.89 | — | ||
| Q4 25 | $1.00 | $0.49 | ||
| Q3 25 | $0.63 | $0.67 | ||
| Q2 25 | $0.25 | $0.07 | ||
| Q1 25 | $-0.49 | $0.55 | ||
| Q4 24 | $1.01 | $0.46 | ||
| Q3 24 | $0.45 | $1.21 | ||
| Q2 24 | $0.41 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | — | $9.7B |
| 总资产 | $2.7B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资ETSYRPRX
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.4B | $618.7M | ||
| Q3 25 | $1.2B | $938.9M | ||
| Q2 25 | $1.2B | $631.9M | ||
| Q1 25 | $649.2M | $1.1B | ||
| Q4 24 | $811.2M | $929.0M | ||
| Q3 24 | $818.9M | $950.1M | ||
| Q2 24 | $759.2M | $1.8B |
总债务ETSYRPRX
| Q1 26 | — | — | ||
| Q4 25 | $2.3B | $9.0B | ||
| Q3 25 | $3.0B | $8.9B | ||
| Q2 25 | $3.0B | $8.0B | ||
| Q1 25 | $2.3B | $7.6B | ||
| Q4 24 | $2.3B | $7.6B | ||
| Q3 24 | $2.3B | $7.6B | ||
| Q2 24 | $2.3B | $7.6B |
股东权益ETSYRPRX
| Q1 26 | — | — | ||
| Q4 25 | $-1.1B | $9.7B | ||
| Q3 25 | $-1.1B | $9.6B | ||
| Q2 25 | $-1.1B | $9.5B | ||
| Q1 25 | $-910.3M | $9.8B | ||
| Q4 24 | $-758.9M | $10.3B | ||
| Q3 24 | $-624.3M | $10.3B | ||
| Q2 24 | $-635.0M | $9.8B |
总资产ETSYRPRX
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.8B | $19.6B | ||
| Q3 25 | $2.7B | $19.3B | ||
| Q2 25 | $2.6B | $18.3B | ||
| Q1 25 | $2.1B | $17.6B | ||
| Q4 24 | $2.4B | $18.2B | ||
| Q3 24 | $2.4B | $18.0B | ||
| Q2 24 | $2.4B | $17.7B |
负债/权益比ETSYRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $725.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $671.2M | — |
| 自由现金流率自由现金流/营收 | 80.7% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 6.93× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $1.3B | — |
8季度趋势，按日历期对齐
经营现金流ETSYRPRX
| Q1 26 | $725.0M | — | ||
| Q4 25 | $317.1M | $827.1M | ||
| Q3 25 | $219.0M | $702.6M | ||
| Q2 25 | $108.1M | $364.0M | ||
| Q1 25 | $49.2M | $596.1M | ||
| Q4 24 | $315.0M | $742.5M | ||
| Q3 24 | $217.4M | $703.6M | ||
| Q2 24 | $151.1M | $658.2M |
自由现金流ETSYRPRX
| Q1 26 | $671.2M | — | ||
| Q4 25 | $315.9M | — | ||
| Q3 25 | $215.0M | — | ||
| Q2 25 | $101.3M | — | ||
| Q1 25 | $45.9M | — | ||
| Q4 24 | $310.9M | — | ||
| Q3 24 | $213.2M | — | ||
| Q2 24 | $147.4M | — |
自由现金流率ETSYRPRX
| Q1 26 | 80.7% | — | ||
| Q4 25 | 35.8% | — | ||
| Q3 25 | 31.7% | — | ||
| Q2 25 | 15.1% | — | ||
| Q1 25 | 7.1% | — | ||
| Q4 24 | 36.5% | — | ||
| Q3 24 | 32.2% | — | ||
| Q2 24 | 22.8% | — |
资本支出强度ETSYRPRX
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.6% | — |
现金转化率ETSYRPRX
| Q1 26 | 6.93× | — | ||
| Q4 25 | 2.86× | 3.86× | ||
| Q3 25 | 2.90× | 2.44× | ||
| Q2 25 | 3.75× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | 2.42× | 3.57× | ||
| Q3 24 | 3.79× | 1.29× | ||
| Q2 24 | 2.85× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ETSY
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
